Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alec S Koo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Urology Practice|June 14, 2023
Review Article: Patient Centered Specialty Practice: A Value Based Care Solution for Urology GroupsAlec S Koo, Dana L Jacoby
Urology|April 8, 2019
Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United StatesJeremy B Shelton, Phil Buffington, Richard Augspurger, et al.
Urology|April 29, 2019
Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United StatesJeremy B Shelton, Thomas A Paivanas, Phil Buffington, et al.
NEJM Evidence|February 6, 2024
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder CancerKarim Chamie, Sam S Chang, Eugene Kramolowsky, et al.
The Journal of Urology|September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder CancerSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary DiseaseSam S Chang, Karim Chamie, Charles A Seabury, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Urology Practice|June 14, 2023
Review Article: Patient Centered Specialty Practice: A Value Based Care Solution for Urology GroupsAlec S Koo, Dana L Jacoby
Urology|April 8, 2019
Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United StatesJeremy B Shelton, Phil Buffington, Richard Augspurger, et al.
Urology|April 29, 2019
Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United StatesJeremy B Shelton, Thomas A Paivanas, Phil Buffington, et al.
NEJM Evidence|February 6, 2024
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder CancerKarim Chamie, Sam S Chang, Eugene Kramolowsky, et al.
The Journal of Urology|September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder CancerSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary DiseaseSam S Chang, Karim Chamie, Charles A Seabury, et al.
Pageof 1